HY-100711-1mg
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
HY-100711-10mg
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
HY-100711-100ug
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
HY-100711-250ug
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
HY-100711-5mg
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
HY-100711-500ug
|
MedChemexpress LLC
|
Prodigiosin [CAS 82-89-3]
|
|
Cancer-programmed cell death
|
|
HY-D0815-10mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-100mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-5mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-50mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-D0815-500mg
|
MedChemexpress LLC
|
Propidium (Iodide) [CAS 25535-16-4]
|
|
COVID-19-immunoregulation
|
|
HY-112697-10mg
|
MedChemexpress LLC
|
Rhodamine B isothiocyanate [CAS 36877-69-7]
|
|
|
|
HY-112697-100mg
|
MedChemexpress LLC
|
Rhodamine B isothiocyanate [CAS 36877-69-7]
|
|
|
|
HY-112697-25mg
|
MedChemexpress LLC
|
Rhodamine B isothiocyanate [CAS 36877-69-7]
|
|
|
|
HY-112697-5mg
|
MedChemexpress LLC
|
Rhodamine B isothiocyanate [CAS 36877-69-7]
|
|
|
|
HY-112697-50mg
|
MedChemexpress LLC
|
Rhodamine B isothiocyanate [CAS 36877-69-7]
|
|
|
|
HY-D1533-10mg
|
MedChemexpress LLC
|
RhoNox-1 [CAS 1447815-38-4]
|
|
|
|
HY-D1533-100mg
|
MedChemexpress LLC
|
RhoNox-1 [CAS 1447815-38-4]
|
|
|
|
HY-D1533-25mg
|
MedChemexpress LLC
|
RhoNox-1 [CAS 1447815-38-4]
|
|
|
|
HY-D1533-5mg
|
MedChemexpress LLC
|
RhoNox-1 [CAS 1447815-38-4]
|
|
|
|
HY-D1533-50mg
|
MedChemexpress LLC
|
RhoNox-1 [CAS 1447815-38-4]
|
|
|
|
HY-D1533-1mL
|
MedChemexpress LLC
|
RhoNox-1 [CAS 1447815-38-4] (10mM in DMSO)
|
|
|
|
HY-P71313-10ug
|
MedChemexpress LLC
|
Siglec-8, Human (HEK293, His)
|
|
|
|
HY-P71313-50ug
|
MedChemexpress LLC
|
Siglec-8, Human (HEK293, His)
|
|
|
|
HY-14602-1g
|
MedChemexpress LLC
|
Tramiprosate [CAS 3687-18-1]
|
|
Cancer-programmed cell death
|
|